Q3 2016 13F Holders as of 9/30/2016
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
117M
-
Number of holders
-
115
-
Total 13F shares, excl. options
-
27.8M
-
Shares change
-
+2.8M
-
Total reported value, excl. options
-
$743M
-
Value change
-
+$77.9M
-
Put/Call ratio
-
6.41
-
Number of buys
-
77
-
Number of sells
-
-30
-
Price
-
$26.78
Significant Holders of Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (CHRS) as of Q3 2016
130 filings reported holding CHRS - Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share as of Q3 2016.
Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (CHRS) has 115 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 27.8M shares
of 117M outstanding shares and own 23.74% of the company stock.
Largest 10 shareholders include FMR LLC (6.51M shares), Kohlberg Kravis Roberts & Co. L.P. (3.06M shares), JPMORGAN CHASE & CO (1.93M shares), WELLINGTON MANAGEMENT GROUP LLP (1.55M shares), BlackRock Fund Advisors (1.39M shares), VANGUARD GROUP INC (1.03M shares), MILLENNIUM MANAGEMENT LLC (1.01M shares), PRICE T ROWE ASSOCIATES INC /MD/ (831K shares), STATE STREET CORP (802K shares), and BlackRock Institutional Trust Company, N.A. (715K shares).
This table shows the top 115 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.